Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes

Abstract

This is the first prospective study with protocol-defined immunomodulating therapies confirming poor renal survival in collapsing variant and showing better renal survival in tip variant among steroid-resistant patients.